Investing.com - Pfizer reported second quarter that beat analysts' expectations on Tuesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.8 on revenue of $13.26B. Analysts polled by Investing.com forecast EPS of $0.75 on revenue of $13.41B. That compared to EPS of $0.81 on revenue of $13.47B in the same period a year earlier. The company had reported EPS of $0.85 on revenue of $13.12B in the previous quarter.
Pfizer follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analysts' expectations on July 18, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar